Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway

Therapeutic response to selective serotonin (5-HT) reuptake inhibitors in Major Depressive Disorder (MDD) varies considerably among patients, and the onset of antidepressant therapeutic action is delayed until after 2 to 4 weeks of treatment. The objective of this study was to analyze changes within...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hongjie, Bogdanov, Mikhail B., Boyle, Stephen H., Matson, Wayne, Sharma, Swati, Matson, Samantha, Churchill, Erik, Fiehn, Oliver, Rush, John A., Krishnan, Ranga R., Pickering, Eve, Delnomdedieu, Marielle, Kaddurah-Daouk, Rima, Network, Pharmacometabolomics Research
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714282/
https://www.ncbi.nlm.nih.gov/pubmed/23874572
http://dx.doi.org/10.1371/journal.pone.0068283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714282/
https://www.ncbi.nlm.nih.gov/pubmed/23874572
http://dx.doi.org/10.1371/journal.pone.0068283

Ejemplares similares